2-(Trifluoromethoxy)benzaldehyde | CAS:94651-33-9

We serve 2-(Trifluoromethoxy)benzaldehyde CAS:94651-33-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-(Trifluoromethoxy)benzaldehyde

Chemical Name:2-(Trifluoromethoxy)benzaldehyde
CAS.NO:94651-33-9
Synonyms:2-(Trifluoromethoxy)benzaldehyde
Molecular Formula:C8H5F3O2
Molecular Weight:190.11900
 
Physical and Chemical Properties:
Density:1.332;
Boiling point:77oC;
Flash point:67.2oC;
Index of Refraction:1.454;
 
Specification:
Appearance:Colorless liquid
Purity:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis
 



Contact us for information like 2-(Trifluoromethoxy)benzaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(Trifluoromethoxy)benzaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(Trifluoromethoxy)benzaldehyde Use and application,2-(Trifluoromethoxy)benzaldehyde technical grade,usp/ep/jp grade.


Related News: That impacts airlines’ business, making it less financially attractive for them to fly those routes to China.N-(4-Methylphenyl)-3-oxobutanamide manufacturer Pharmaceutical intermediates and APIs belong to the fine chemical industry.5,8-dibromobenzo[c]phenanthrene supplier Pharmaceutical intermediates and APIs belong to the fine chemical industry.Methyl 2-bromohexanoate vendor On the basis of achieving low-cost and high-quality processes, production capacity will become the core driving force for API companies to break through sales bottlenecks.Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.